COMP <GO>
AUR vs HNGE // RSI-14 & 200D SMA MOMENTUM
Aurora Innovation Inc. (NASDAQ) VS. Hinge Health Inc. (NYSE) • 15-METRIC TALLY: AUR 2
— HNGE 7
▲ RSI-14 & 200D SMA MOMENTUM LEADER: HNGE
LAST: $4.23 (-2.98%) • MKT CAP: $8.81B
rsi-technicals
31.3
LAST: $115.48 (+1.01%) • MKT CAP: $9.22B
rsi-technicals
63.7
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AUR VS. HNGE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AUR | HNGE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | -30.00% | 79.60% | -109.60 | HNGE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.88% | 1.81% | -8.69 | HNGE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 18.70% | 50.60% | -31.90 | HNGE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 22.56 | 12.12 | +10.44 | AUR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | HNGE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 31.3 | 63.7 | -32.40 | HNGE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.22 | 1.24 | -0.02 | HNGE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.0x | 29.0x | -1.00 | AUR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.81B | $9.22B | -$415.8M | HNGE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AUR REV | HNGE REV | AUR GROSS % | HNGE GROSS % | AUR FCF | HNGE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.0M | $587.9M | -466.7% | 79.6% | -$612.0M | $170.7M |
| FY 2024 | $2.20B | $390.4M | — | 76.8% | -$645.0M | $48.0M |
| FY 2023 | $2.34B | $292.7M | — | — | -$598.0M | -$77.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AUR // BETA 1.22
HNGE // BETA 1.24